Connect with us


What to Watch for Next in the Coronavirus Vaccine Race – Motley Fool

Requests for Emergency Use Authorization and formal FDA approvals are next on the agenda.



post featured image

The next few weeks represent a critical moment in the coronavirus vaccine race. That’s because a vaccine may soon be authorized for use. Pfizer (NYSE:PFE) recently became the first vaccine developer to apply for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). And four other programs out of the U.S. and Europe are close behind.
The pace of this race is accelerating as the finish line approaches. So, for investors hoping to identify the near-term winners, it’s important…

Click here to view the original article.

Continue Reading

You might also like ...

post featured image
Asymptomatic infection blunder let Covid-19 spin out of control – STAT – STAT
post featured image
WHO Changes CCP Virus Test Criteria in Attempt to Reduce False Positives – The Epoch Times
post featured image
Groundbreaking Study Explains ‘Preexisting Immunity’ to Covid-19 Among Some Populations – Sputnik International